argenx to Present at Upcoming Investor Conferences

Barchart · 11/26 00:00

November 26, 2024

Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following upcoming investor conferences in December.

Read more at globenewswire.com